Tissue expression and biochemical characterization of human 2-amino 3-carboxymuconate 6-semialdehyde decarboxylase, a key enzyme in tryptophan catabolism

FEBS Journal

Volumn 274, Issue 3, 2007, Pages 827-840

  Pucci, Lisa ^a   Perozzi, Silvia ^a   Cimadamore, Flavio ^a   Orsomando, Giuseppe ^a   Raffaelli, Nadia ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

ACMSD; NAD biosynthesis; Picolinate; Quinolinate; Tryptophan catabolism

Indexed keywords

2 AMINO 3 CARBOXYMUCONATE 6 SEMIALDEHYDE DECARBOXYLASE; BACTERIAL ENZYME; COBALT; COMPLEMENTARY DNA; ENZYME; FERROUS ION; KYNURENIC ACID; PICOLINIC ACID; QUINOLINIC ACID; RECOMBINANT PROTEIN; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; CATABOLISM; CHEMICAL ANALYSIS; ENZYME ACTIVITY; EXPRESSION VECTOR; HUMAN; HUMAN TISSUE; KIDNEY; LIVER; MICHAELIS CONSTANT; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; STATISTICAL SIGNIFICANCE;

AMINO ACID SEQUENCE; BRAIN; CARBOXY-LYASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION PROFILING; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROPHOBICITY; ISOENZYMES; KIDNEY; KINETICS; LIVER; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PROTEIN STRUCTURE, SECONDARY; QUINOLINIC ACID; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; TRYPTOPHAN;

BACTERIA (MICROORGANISMS);

EID: 33846463399     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05635.x     Document Type: Article

References (49)

1. Bender DA (1983) Biochemistry of tryptophan in health and disease. Mol Aspects Med 6, 101-197.
2. Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N & Ruggieri S (2004) Enzymology of NAD homeostasis in man. Cell Mol Life Sci 61, 19-34.
3. Stone TW (2001) Endogenous neurotoxins from tryptophan. Toxicon 39, 61-73.
4. Rios C & Santamaria A (1991) Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res 16, 1139-1143.
5. Schwarcz R, Whetsell WO & Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219, 316-318.
6. Burns LH, Pakzaban P, Deacon TW, Brownell AL, Tatter SB, Jenkins BG & Isacson O (1995) Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington's disease. Neuroscience 64, 1007-1017.
7. Guidetti P, Luthi-Carter RE, Augood SJ & Schwarcz R (2004) Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease. Neurobiol Dis 17, 455-461.
8. Guillemin GJ, Wang L & Brew BJ (2005) Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. J Neuroinflam 2, 16.
9. Guillemin GJ, Brew BJ, Noonan CE, Takikawa O & Culler KM (2005) Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathol Appl Neurobiol 31, 395-404.
10. Bosco MC, Rapisarda A, Reffo G, Massazza S, Pastorino S & Varesio L (2003) Macrophage activating properties of the tryptophan catabolyte picolinic acid. In Developments in Triptophan and Serotonin Metabolism (Allegri G, Costa CVL, Ragazzi E, Steinhart H & Varesio L, eds), pp. 55-65. Kluwer Academic/Plenum Publishers, Norwell, MA.
11. Leuthauser SW, Oberley LW & Oberley TD (1982) Antitumor activity of picolinic acid in CBA/J mice. J Natl Cancer Inst 68, 123-129.
12. Blasi E, Bauer D, Barluzzi R, Mazzolla R & Bistoni F (1994) Pattern of cytokine gene expression in brains of mice protected by picolinic acid against lethal intracerebral infection with Candida albicans. J Neuroimmunol 52, 205-213.
13. Ogata S, Takeuchi M, Fujita H, Shibata K, Okumura K & Taguchi H (2000) Apoptosis induced by niacin-related compounds in K562 cells but not in normal human lymphocytes. Biosci Biotechnol Biochem 64, 1142-1146.
14. Fernandez-Pol JA, Klos DJ & Hamilton PD (2001) Antiviral, cytotoxic and apoptotic activities of picolinic acid on human immunodeficiency virus-1 and human herpes simplex virus-2 infected cell. Anticancer Res 21, 3773-3776.
15. Rebello T, Lonnerdal B & Hurley L (1982) Picolinic acid in milk, pancreatic juice and intestine: inadequate for role in zinc absorption. Am J Clin Nutr 35, 1-9.
16. Evans GW & Johnson PE (1980) Characterization and quantitation of a zinc binding ligand in human milk. Pediatr Res 14, 867-871.
17. Dazzi C, Candiano S, Massazza S, Ponzetto A & Varesio L (2001) New high-performance liquid chromatography method for the detection of picolinic acid in biological fluids. J Chromatogr B 751, 61-68.
18. Medana IM, Day NPJ, Salahifar-Sabet H, Stocker R, Smythe G, Bwanaisa L, Njobvu A, Kayira K, Turner GDH, Taylor TT et al. (2003) Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis 188, 844-849.
19. Clark CJ, Mackay GM, Smythe GA, Bustamante S, Stone TW & Phillip RS (2005) Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition. Infect Immun 73, 5249-5251.
20. Beninger RJ, Colton AM, Ingles JL, Jhamandas K & Boegman RJ (1994) Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry. Neuroscience 61, 603612.
21. Li T, Iwaki H, Fu R, Hasegawa Y, Zhang H & Liu A (2006) α-Amino-β-carboxymuconic-ε-semialdehyde decarboxylase (ACMSD) is a new member of the amidohydrolase superfamily. Biochemistry 45, 6628-6634.
22. Ichiyama A, Nakamura S, Kawai H, Honjo T, Nishizuka Y, Hayaishi O & Senoh S (1965) Studies on the metabolism of the benzene ring of tryptophan in mammalian tissues. Enzymic formation of α-aminomuconic acid from 3-hydroxyanthranilic acid. J Biol Chem 240, 740-749.
23. Egashira Y, Kouhashi H, Ohta T & Sanada H (1996) Purification and properties of α-amino-β-carboxymuconic-ε-semialdehyde decarboxylase (ACMSD), key enzyme of niacin synthesis from tryptophan, from hog kidney. J Nutr Sci Vitaminol 42, 173-183.
24. Tanabe A, Egashira Y, Fukuoka SI, Shibata K & Sanada H (2002) Purification and molecular cloning of rat 2-amino-3-carboxymuconate-6- semialdehyde. Biochem J 361, 567-575.
25. Egashira Y, Murotani G, Tanabe A, Saito K, Uehara K, Morise A, Sato M & Sanada H (2004) Differential effects of dietary fatty acids on rat liver α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase activity and gene expression. Biochim Biophys Acta 1686, 118-124.
26. Fukuwatari T, Ohsaki S, Fukuoka SI, Sasaki R & Shibata K (2004) Phtalate esters enhance quinolinate production by inhibiting α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD), a key enzyme of the tryptophan pathway. Toxicol Sci 81, 302-308.
27. Shin M, Ohnishi M, Iguchi S, Sano K & Umezawa C (1999) Peroxisome-proliferator regulates key enzymes of the tryptophan-NAD pathway. Toxicol Appl Pharmacol 158, 71-80.
28. Kimura N, Fukuwatari T, Sasaki R & Shibata K (2005) The necessity of niacin in rats fed on a high protein diet. Biosci Biotechnol Biochem 69, 273-279.
29. Tanabe A, Egashira Y, Fukuoka SI, Shibata K & Sanada H (2002) Expression of rat hepatic 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase is affected by a high protein diet and by streptozotocin-induced diabetes. J Nutr 132, 1153-1159.
30. Shin M, Kim I, Inoue Y, Kimura S & Gonzalez FJ (2006) Regulation of mouse hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme in the tryptophan-nicotinamide adenine dinucleotide pathway, by hepatocyte nuclear factor 4alpha and peroxisome proliferator- activated receptor alpha. Mol Pharmacol 70, 1281-1290.
31. Colabroy KL & Begley TP (2005) Tryptophan catabolism: identification and characterization of a new degradative pathway. J Bacteriol 187, 7866-7869.
32. Muraki T, Taki M, Hasegawa Y, Iwaki H & Lau PCK (2003) Prokaryotic homologs of the eukaryotic 3-hydroxyanthranilate 3,4-dioxygenase and 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase in the 2-nitrobenzoate degradation pathway of Pseudomonas fluorescens strain KU-7. Appl Environ Microbiol 69, 1564-1572.
33. Li T, Walker AL, Iwaki H, Hasegawa Y & Liu A (2005) Kinetic and spectroscopic characterization of ACMSD from Pseudomonas fluorescens reveals a pentacoordinate mononuclear metallocofactor. J Am Chem Soc 127, 12282-12290.
34. Martynowski D, Eyobo Y, Li T, Yang K, Liu A & Zhang H (2006) Crystal structure of α-amino-β-carboxymuconic-ε-semialdehyde decarboxylase: insight into the active site and catalytic mechanism of a novel decarboxylase reaction (2006). Biochemistry 45, 10412-10421.
35. Liu A & Zhang H (2006) Transition metal-catalyzed nonoxidative decarboxylation reactions. Biochemistry 45, 10407-10411.
36. Fukuoka SI, Ishiguro K, Yanagihara K, Tanabe A, Egashira Y, Sanada H & Shibata K (2002) Identification and expression of a cDNA encoding human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD). J Biol Chem 277, 35162-35167.
37. Kyte J & Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157, 105-132.
38. Pawlak D, Tankiewicz A, Matys T & Buczko W (2003) Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. J Physiol Pharmacol 54, 175-189.
39. Saito K, Fujigaki S, Heyes MP, Shibata K, Takemura M, Fuji H, Wada H, Noma A & Seishima M (2000) Mechanism of increases in 1-kynurenine and quinolinic acid in renal insufficiency. Am J Physiol Renal Physiol 279, F565-F572.
40. Egashira Y, Nagaki S & Sanada H (2006) Tryptophan-niacin metabolism in rat with puromycin aminonucleoside-induced nephrosis. Int J Vitam Nutr Res 76, 28-33.
41. Fukuwatari T, Morikawa Y, Hayakawa F, Sugimoto E & Shibata K (2001) Influence of adenine-induced renal failure on tryptophan-niacin metabolism in rats. Biosci Biotechnol Biochem 65, 2154-2161.
42. Bender DA & Olufunwa R (1988) Utilization of tryptophan, nicotinamide and nicotinic acid as precursors for nicotinamide nucleotide synthesis in isolated rat liver cells. Br J Nutr 59, 279-287.
43. Ying W (2006) NAD and NADH in cellular functions and cell death. Front Biosci 11, 3129-3148.
44. Sasaki Y, Araki T & Milbrandt J (2006) Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J Neuroscience 26, 8484-8491.
45. Cooper BF, Sideraki V, Wilson DK, Dominguez DY, Clark SW, Quiocho FA & Rudolph FB (1997) The role of divalent cations in structure and function of murine adenosine deaminase. Protein Sci 6, 1031-1037.
46. Schagger H & Von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166, 368-379.
47. Pichia Expression Kit A Manual of Methods for Expression of Recombinant Proteins in Pichia Pastoris. Invitrogen Corporation, San Diego, CA.
48. Laskowski RA, MacArthur MW, Moss DS & Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 26, 283-291.
49. Humphrey W, Dalke A & Schulten K (1996) VMD: visual molecular dynamics. J Molec Graphics 14 1, 19-25.